Clinical Trial Update: SC12267 (4SC-101) for Treatment of Patients With Inflammatory Bowel Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of SC12267 (4SC-101) for inflammatory bowel disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• SC12267 (4SC-101) (SC12267)

Snippet

Sponsor: 4SC AG | Conditions: Inflammatory Bowel Disease (IBD) | Phase 2 | Status: COMPLETED